CG
IMGN

Carmignac Gestion’s Immunogen Inc IMGN Stock Holding History

Carmignac Gestion’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-114,380
Closed -$3.39M – 164
2023
Q4 		$3.39M Buy
+114,380
New +$2.28M 0.06% 84

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carmignac Gestion's IMGN Position: Q1 2024 in Review

Carmignac Gestion sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 114,380 shares — an estimated $3.39M sold.

Carmignac Gestion first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $3.39M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Carmignac Gestion reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Carmignac Gestion sold 114,380 Immunogen Inc shares in Q1 2024, an estimated $3.39M.
  • Carmignac Gestion first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Carmignac Gestion's Immunogen Inc position peaked at $3.39M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Carmignac Gestion's 13F filing for Q1 2024, filed 14 May 2024.